Formerly Astex PharmaceuticalsProvided operational oversight of multiple oncology programs and studies Provided strategic input for multiple oncology programs Responsible for global timelines and budgets Lead and provide oversight of global cross functional study teams Lead and provide oversight of CROs and additional vendors Provide oversight and contribute to the development of protocols and other program documents Managed up to four direct reports Ensured resources are managed sufficiently across portfolios Developed new eTMF system for company in partnership with Ostuka and Taiho Developed and assess SOPs and alignment with global partners within Otsuka Holdings Responsible for oversight of LOINC collection and vendor for company wide effort Integral member of alliance partnership with additional Otsuka companies across a portfolio

Provided operational oversight of multiple oncology programs and studies Provided strategic input for multiple oncology programs Responsible for global timelines and budgets Lead and provide oversight of global cross functional study teams Lead and provide oversight of CROs and additional vendors Provide oversight and contribute to the development of protocols and other program documents Managed up to four direct reports Ensured resources are managed sufficiently across portfolios Developed new eTMF system for company in partnership with Ostuka and Taiho Developed and assess SOPs and alignment with global partners within Otsuka Holdings Responsible for oversight of LOINC collection and vendor for company wide effort Integral member of alliance partnership with additional Otsuka companies across a portfolio

Functional service provider through Execupharm serving Seattle Genetics.Provided Project Management oversight of oncology projects Responsible for global timelines and budgets Managed global cross functional study teams Provided oversight of CROs Provided vendor management and oversight Partnered with additional sponsor company to transition projects within partnerships and assist alliance partnership Conducted programs across multiple Sponsors

Providing support and oversight within the global Oncology Therapeutic Area for Takeda Pharmaceuticals Management of projects on a global scale with focus on start-up, timelines, budget, vendor management, and teams management.

Effectively managed projects across portfolios as well as global teams Created strategic strategic and operational plans tailored to the particular needs of all phases of studies in development phase studies globally. Lead cross-functional teams Multiple therapeutic areas included Provided expertise and guidance with global trial needs to Clients and staff Subject matter expert for non interventional projects and programs Supported technological solutions for trials including wearables and telehealth Primarily responsible and accountable for accomplishing contractual project deliverables Participated in bid defense meetings as appropriate Assisted the Business Development group with revising their overall strategy and materials for bid defenses and proposals Worked closed with the newly developed office in Japan to provide both Business Development and Clinical Operations support to build their office capabilities Provided subject-matter expert input into late phase proposals Oversaw financial management of projects Provided vendor oversight Provided support and expertise to teams for country level specifics

Clinical Program Manager in Oncology TA• Optimized drug development by providing expert scientific input Coordinated the planning and execution of multiple global Phase 3 Oncology trials Directed resources, projects, ongoing trials and new trial start-ups Managed study budgets and project timelines for global trials Selected and managed multiple vendors Ensured studies were conducted within regulatory requirements, timeframes and budgets Developed clinical protocols and study materials Managed approximately five clinical operations team members

• Optimized drug development by providing expert scientific input Coordinated the planning and execution of multiple global Phase 3 Oncology trials Directed resources, projects, ongoing trials and new trial start-ups Managed study budgets and project timelines for global trials Selected and managed multiple vendors at the study and corporate levels Ensured studies are conducted within regulatory requirements, timeframes and budgets Developed clinical protocols and study materials Provided strategic program level oversight Managed clinical operations team members

• Coordinated the planning and execution of post-marketing studies, phase 1, phase 2 and post-marketing studies Directed resources, projects, ongoing trials and new trial start-ups Managed study budgets and project timelines for global trials Selected and managed multiple vendors at the study and corporate levels Developed clinical protocols and study materials Managed approximately three clinical operations team members Oversaw CRO activities • Core team member for eTMF development and implementation representing Clinical Operations and Medical Affairs.• Managed multiple individual study budgets and vendor budgets up to 3 million/year.

Developed and coordinated the planning and management of Phase 3 global Urology studies including timelines, budgets, vendors, internal and external teams, multiple CROs in multiple regions Managed teams to oversee sites, study initiation, execution, monitoring and completion Assisted in developing monitoring plans, ICFs, study manuals, pharmacy manuals, training materials, video scripts, and design CRFs Managed in-house CRAs, contract CRAs, and administrative personnel Managed study budget and project timelines Developed regulatory responses and ethics committee responses for Latin America Migration Oversight Committee member for Project Phoenix for development and migration activities related to the electronic document management system Provided consultation from the Clinical Department for development and integration of multiple electronic systems across the company Provided vendor oversight

Managed all aspects of global clinical trials Developed and coordinated the planning and execution of global Phase 3 studies Managed activities around study sites, study initiation, execution, monitoring and completion Interfaced with key individuals in Regulatory Affairs, Project Management, Research Compliance, Marketing, and Data Management/Biostatistics Assisted in developing monitoring plans, ICFs, study manuals, pharmacy manuals, training materials, and video scripts, and design CRFs Managed study budget and project timelines Developed regulatory responses and ethics committee responses for Latin America

• Managed all aspects of spontaneous regulatory requests for data Managed all aspects of completion of regulatory compliance documents for neuroscience compounds Participated as core team member in activities involved in improving and standardizing the overarching external research process from a global perspective utilizing Six Sigma methodology. Co-led team to develop global training, SOPs, and global communications at all levels Managed External Research Programs for the Neuroscience Platform compounds as the Gatekeeper for Zyprexa, Symbyax, and Strattera prior to becoming the Gatekeeper for Cymbalta and Yentreve. Oversee all aspects of the external research programs for all Neuroscience compounds and Yentreve including but not limited to initial review, Committee review and decision-making processes, and budget Reviewed and managed individual study budgets as well as manage the overall budgets related to external research for the neuroscience Global Brand Development Teams and Platform Teams Managed forecasted and actual amounts as well as decisions related to new commitments. Budgets ranged from 1.2 million per compound to 3.2 million per compound Managed Lilly sponsored clinical trials within the Neuroscience division as an in-house clinical development associate Managed Phase 3 studies in Neuroscience with responsibilities that included but were not limited to managing study communications, ensuring site and monitor compliance with the protocol and FDA/GCP/ICH regulations, managing study drug shipments, managing serious adverse event reporting, increasing enrollment rates, facilitating milestone payments, etc.